Company intelligence / Profile preview

Zhuzhou Qianjin Pharmaceutical Co., Ltd.

Ownership: Private
Employees: ~5335
Development stage: Commercial

Overview

Zhuzhou Qianjin Pharmaceutical has a broad commercial portfolio with multiple approved products, especially in gynecology and chronic disease management. The company also maintains an active R&D pipeline with at least five herbal medicines and four small molecule drugs targeting nervous system, infectious, endocrine/metabolic disorders, among others. Several programs have reached approval status in China.

Therapeutic areas: EndocrinologyWomen's HealthCardiovascularNeurologyInfectious Diseases
Modalities: Small molecule drugsHerbal medicines
Industry: Biotech

Drug pipeline

9 assets

FuKe Qianjin Capsules

8 more assets in the full pipeline.

Request access →

Beyond the preview

Go deeper on Zhuzhou Qianjin Pharmaceutical Co., Ltd..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zhuzhou Qianjin Pharmaceutical Co., Ltd..

Explore the full profile